Haiping Xu

Haiping Xu

Auto-generated profile, based on publicly available information

Haiping Xu

Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
YBYuhan Bao
Yuhan Bao
CWChunxiang Wang
Chunxiang Wang
HXHaiping Xu
Haiping Xu
YLYongjie Lai
Yongjie Lai
YYYupei Yan
Yupei Yan
Yibo WuYibo Wu
Yibo Wu
Background: Improving the health self-management level of patients with tuberculosis (TB) is significant for reducing drug resistance, improving the cure rate, and controlling the prevalence of TB. Mobile health (mHealth) interventions based on behavioral science theories may be promising to achieve this goal. Objective: This study aims to explore and conduct an mHealth intervention based on the Integrated Theory of Health Behavior Change (ITHBC) in patients with pulmonary TB to increase their ability of self-care management. Methods: A prospective randomized controlled study was conducted from May to November 2020. A total of 114 patients who were admitted consecutively to the TB clinic of Harbin Chest Hospital, China from May 2020 to August 2020 were recruited by convenience sampling. Patients were divided into the control group and intervention group, and all received a 3-month intervention. Patients in the intervention group and the control group received routine medical and nursing care in the TB clinic, including the supervision of their medications. In addition, pharmacist-assisted mHealth (WeChat) intervention based on the ITHBC theory about TB management was provided to the intervention group. The primary outcome was self-management behavior, while the secondary outcomes were TB awareness, self-efficacy, social support, and degree of satisfaction with health education. The outcomes were measured using web-based self-designed and standard questionnaires administered at baseline and at the end point of the study. Intergroup data were assessed using the Mann-Whitney U test, whereas intragroup data were assessed with the Wilcoxon test (for paired samples). Results: A total of 112 patients (59 in intervention group and 53 in control group) completed the study. After the intervention, a statistically significant increase was noted in the scores of each item of self-care management behaviors compared with the scores at the baseline (P<.001) in the intervention group. The scores of all self-care management behaviors of the control group were lower than those of all self-care management behaviors in the intervention group (all P<.05), except for the item “cover your mouth and nose when coughing or sneezing” (P=.23) and item “wash hands properly” (P=.60), which had no statistically significant difference from those in the intervention group. Compared with those at baseline, TB knowledge awareness, self-efficacy, social support, and degree of satisfaction with health education in the intervention group increased significantly (P<.001), and the intervention group had significantly higher scores than the control group (P<.001). Conclusions: mHealth intervention for TB self-management based on ITHBC could deepen the understanding of patients with TB about their disease and improve their objective initiative and self-care management behaviors, which were beneficial for promoting compliance behavior and quality of prevention and control for pulmonary TB. Trial Registration: Chinese Clinical Trial Registry ChiCTR2200055557; https://tinyurl.com/4ray3xnw

14 October 2021 in JMIR Preprints
Verified
Preprint
Open access
YBYuhan Bao
Yuhan Bao
CWChunxiang Wang
Chunxiang Wang
HXHaiping Xu
Haiping Xu
YLYongjie Lai
Yongjie Lai
YYYupei Yan
Yupei Yan
Yibo WuYibo Wu
Yibo Wu
BACKGROUND Improving the health self-management level of patients with tuberculosis (TB) is significant for reducing drug resistance, improving the cure rate, and controlling the prevalence of TB. Mobile health (mHealth) interventions based on behavioral science theories may be promising to achieve this goal. OBJECTIVE This study aims to explore and conduct an mHealth intervention based on the Integrated Theory of Health Behavior Change (ITHBC) in patients with pulmonary TB to increase their ability of self-care management. METHODS A prospective randomized controlled study was conducted from May to November 2020. A total of 114 patients who were admitted consecutively to the TB clinic of Harbin Chest Hospital, China from May 2020 to August 2020 were recruited by convenience sampling. Patients were divided into the control group and intervention group, and all received a 3-month intervention. Patients in the intervention group and the control group received routine medical and nursing care in the TB clinic, including the supervision of their medications. In addition, pharmacist-assisted mHealth (WeChat) intervention based on the ITHBC theory about TB management was provided to the intervention group. The primary outcome was self-management behavior, while the secondary outcomes were TB awareness, self-efficacy, social support, and degree of satisfaction with health education. The outcomes were measured using web-based self-designed and standard questionnaires administered at baseline and at the end point of the study. Intergroup data were assessed using the Mann-Whitney U test, whereas intragroup data were assessed with the Wilcoxon test (for paired samples). RESULTS A total of 112 patients (59 in intervention group and 53 in control group) completed the study. After the intervention, a statistically significant increase was noted in the scores of each item of self-care management behaviors compared with the scores at the baseline (P<.001) in the intervention group. The scores of all self-care management behaviors of the control group were lower than those of all self-care management behaviors in the intervention group (all P<.05), except for the item “cover your mouth and nose when coughing or sneezing” (P=.23) and item “wash hands properly” (P=.60), which had no statistically significant difference from those in the intervention group. Compared with those at baseline, TB knowledge awareness, self-efficacy, social support, and degree of satisfaction with health education in the intervention group increased significantly (P<.001), and the intervention group had significantly higher scores than the control group (P<.001). CONCLUSIONS mHealth intervention for TB self-management based on ITHBC could deepen the understanding of patients with TB about their disease and improve their objective initiative and self-care management behaviors, which were beneficial for promoting compliance behavior and quality of prevention and control for pulmonary TB. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2200055557; https://tinyurl.com/4ray3xnw

3 June 2026 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
HXHaiping Xu
Haiping Xu
WYWenyu Yang
Wenyu Yang
TLTony Lai
Tony Lai
BMBrendan McMullan
Brendan McMullan
DYDaniel Yeoh
Daniel Yeoh
AGAmanda Gwee
Amanda Gwee
Vancomycin is used to treat serious gram-positive infections in children; however, effective dosing information for those aged 3 months to 18 years is limited. We aimed to determine an optimized dosing strategy for this age group. A population pharmacokinetic model was developed using data from The Royal Children’s Hospital (RCH), Melbourne. Children aged 3 months to 18 years who received vancomycin were included. The model was externally validated with data from the Children’s Hospital at Westmead (CHW), Sydney Children’s Hospital (SCH), and Perth Children’s Hospital (PCH). Simulations were performed to evaluate the standard dosing regimen and propose an optimized strategy, targeting an AUC 24–48 of 400–650 mg·h/L. An empirical loading dose was evaluated against the same therapeutic range for AUC 0–24 and AUC 24–48 . The RCH data set included 3,687 vancomycin concentrations from 627 children. A two-compartment model with renal maturation best described the data. External validation (PCH 175, SCH 58, and CHW 170 concentrations) showed adequate predictive performance. The optimized dosing strategy achieved a target attainment of 73% versus 44% with the standard 15 mg/kg of body weight administered every 6 h. Improvement was most notable in patients <4 years, where the probability of target attainment (PTA) increased from 10.5%–48% to 66.1%–80% with the optimized regimen. A 25 mg/kg loading dose significantly increased the initial 24-h PTA to 57%, compared to 23% without a loading dose. We developed an optimized vancomycin dosing strategy that achieved the therapeutic target in 73% of children. This regimen requires prospective clinical validation.